Xylem Inc. filings document the regulatory disclosures of a public operating company focused on water solutions and resource management. Recent Form 8-K reports furnish quarterly and annual financial results, including press-release exhibits for orders, revenue, earnings measures and guidance-related disclosures.
Other Xylem filings record capital actions such as common-stock repurchase authorization, while definitive proxy materials cover governance, shareholder voting matters and executive compensation disclosures, including equity-award and pay-versus-performance information.
Xylem Inc. President and CEO Matthew Francis Pine reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 1,846 shares of Xylem common stock were withheld to cover associated tax liabilities, at a value of $126.19 per share. After this withholding, Pine directly owned 45,105 Xylem shares, and a separate indirect holding line reflects 34,007 shares held through the Matthew F. Pine and Angeles Lopez Guerrero Living Trust.
Xylem Inc. executive Michael J. McGann, EVP & President, MCS, reported a tax-related share disposition. On March 5, 2026, 238 shares of common stock were withheld at $126.19 per share to cover taxes from vesting restricted stock units granted on March 5, 2025. After this withholding, he directly owned 11,987 Xylem common shares.
Xylem Inc. Executive Vice President and Chief Financial Officer William K. Grogan reported a tax-related share disposition. On March 5, 2026, 641 shares of Xylem common stock were withheld at $126.19 per share to cover the tax liability from vesting restricted stock units granted on March 5, 2025.
These shares were withheld under the Xylem 2011 Omnibus Incentive Plan (as amended). After this tax-withholding disposition, Grogan directly owned 39,510 shares of Xylem common stock.
Xylem Inc. executive Meredith Emmerich, EVP & President, Applied Water, reported a tax-related share disposition. On March 5, 2026, 158 shares of common stock were withheld at $126.19 per share to cover taxes due upon vesting of restricted stock units granted on March 5, 2025. After this withholding, Emmerich directly held 5,447 common shares.
Xylem Inc. executive Stacy Cozad reported a small tax-related share disposition. On March 5, 2026, 70 shares of common stock were withheld at $126.19 per share to cover taxes due on the vesting of restricted stock units granted on September 1, 2025. After this withholding, Cozad directly owns 2,233 shares of Xylem common stock.
Xylem Inc. executive Albert Cho reported a tax-related share disposition. The company withheld 177 shares of common stock to cover taxes due on the vesting of restricted stock units, leaving him with 16,411 shares of Xylem common stock held directly.
Xylem Inc. executive Rodney Aulick reported a tax-related share disposition. On March 5, 2026, he disposed of 234 shares of Xylem common stock at $126.19 per share through a tax-withholding transaction tied to vested restricted stock units. After this withholding, he directly owns 73,683 Xylem common shares.
Xylem Inc. executive vice president of strategy Albert Cho reported a mix of equity awards and related tax withholdings. On March 2, 2026 he received non-qualified stock options for 3,713 shares at $128.98 per share and a restricted stock unit award of 1,042 common shares.
Footnotes show several performance-based stock units granted in prior years vested based on Total Shareholder Return, Adjusted EBITDA, Revenue and ESG performance, increasing his common stock holdings. Shares totaling 1,610, 295 and 371 were withheld at $128.98 per share to cover tax liabilities tied to these vestings and restricted stock units. After these transactions, Cho directly owned 16,588 shares of Xylem common stock.
Xylem Inc. Pres. & CEO Matthew Francis Pine reported multiple equity compensation changes. On March 2, 2026, he received a grant of 57,386 non-qualified stock options with an exercise price of $128.98, scheduled to vest in one-third increments on March 1, 2027, 2028 and 2029.
He also acquired 16,105 shares of common stock as awards, and on March 1, 2026 vested performance-based stock units delivered 5,243, 4,328, 2,943 and 2,152 shares tied respectively to Total Shareholder Return, Adjusted EBITDA, Revenue and ESG performance, plus additional shares from dividend reinvestment.
To cover tax liabilities from these vestings, the company withheld 4,927, 847 and 2,316 shares of common stock at $128.98 per share. After these transactions, Pine holds both directly owned shares and an indirect position through the Matthew F. Pine and Angeles Lopez Guerrero Living Trust.
Xylem Inc. executive Meredith Emmerich received new equity awards. On March 2, 2026, Emmerich was granted 5,739 non-qualified stock options with an exercise price of $128.98 per share and 1,610 shares of common stock as a restricted stock unit award.
Both the options and restricted stock units were granted under the Xylem 2011 Omnibus Incentive Plan and are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. The filing also notes additional common shares from dividend reinvestment.